These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17012833)

  • 1. Clonal heterogeneity of tumor may be due to continuous influx of newly transformed cells.
    Lichtenstein AV
    Cancer Biol Ther; 2006 Oct; 5(10):1263-4. PubMed ID: 17012833
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous influx of newly transformed cells as a source of tumor clonal heterogeneity].
    Likhtenshteĭn AV
    Vopr Onkol; 2007; 53(5):596-7. PubMed ID: 18154128
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer. Heterogeneity and tumor history.
    Shibata D
    Science; 2012 Apr; 336(6079):304-5. PubMed ID: 22517848
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour heterogeneity and clonality--an old theme revisited.
    Fey MF; Tobler A
    Ann Oncol; 1996 Feb; 7(2):121-8. PubMed ID: 8777166
    [No Abstract]   [Full Text] [Related]  

  • 5. Constraints in cancer evolution.
    Venkatesan S; Birkbak NJ; Swanton C
    Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral Heterogeneity of the Epigenome.
    Mazor T; Pankov A; Song JS; Costello JF
    Cancer Cell; 2016 Apr; 29(4):440-451. PubMed ID: 27070699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation.
    Ohsawa S; Takemoto D; Igaki T
    J Biochem; 2014 Sep; 156(3):129-36. PubMed ID: 25012819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal cooperativity in heterogenous cancers.
    Zhou H; Neelakantan D; Ford HL
    Semin Cell Dev Biol; 2017 Apr; 64():79-89. PubMed ID: 27582427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor heterogeneity: causes and consequences.
    Marusyk A; Polyak K
    Biochim Biophys Acta; 2010 Jan; 1805(1):105-17. PubMed ID: 19931353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor genetic heterogeneity].
    Yang YL; Chu JY; Wang MR
    Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cell hybrids: analysis of transformation and tumorigenicity.
    Stanbridge EJ; Der CJ; Doersen CJ; Nishimi RY; Peehl DM; Weissman BE; Wilkinson JE
    Science; 1982 Jan; 215(4530):252-9. PubMed ID: 7053574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catch my drift? Making sense of genomic intra-tumour heterogeneity.
    Sottoriva A; Barnes CP; Graham TA
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):95-100. PubMed ID: 28069394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular heterogeneity in tumours.
    Woodruff MF
    Br J Cancer; 1983 May; 47(5):589-94. PubMed ID: 6342645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
    McGranahan N; Swanton C
    Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraclonal heterogeneity in tumors and its impact on precision medicine].
    Roux J; Gouzé JL; Hofman P
    Med Sci (Paris); 2015 Jan; 31(1):28-31. PubMed ID: 25658727
    [No Abstract]   [Full Text] [Related]  

  • 17. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal dynamics of progressive neoplastic transformation.
    Chow M; Rubin H
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6976-81. PubMed ID: 10359824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Heterogeneity as a Pre-analytical Source of Variability.
    Stanta G
    Recent Results Cancer Res; 2015; 199():35-43. PubMed ID: 25636427
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
    Prick J; de Haan G; Green AR; Kent DG
    Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.